|

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

RECRUITINGSponsored by Kansas City Heart Rhythm Research Foundation
Actively Recruiting
SponsorKansas City Heart Rhythm Research Foundation
Started2023-07-24
Est. completion2025-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06075628

Summary

This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Subjects must be at least 18 years of age.
* Subjects underwent LAA closure with Watchman/Watchman FLX or Amplatzer Amulet at our institution from January 2019 till June 2022

Exclusion Criteria:

* No definite exclusion criteria are defined for the study as all patients with Watchman-FLX or Amplatzer Amulet will be included in the study.

Conditions3

Atrial FibrillationHeart DiseaseIschemic Stroke, Acute

Locations1 site

Kansas City Heart Rhythm Institute
Overland Park, Kansas, 66211
Donita Atkins816-651-1969Datkins@kchrf.com

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.